| For: | Jiang C, Zhang ZH, Li JX. Current status of drug therapy for chronic hepatitis B. World J Gastroenterol 2025; 31(2): 99443 [PMID: 39811512 DOI: 10.3748/wjg.v31.i2.99443] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i2/99443.htm |
| Number | Citing Articles |
| 1 |
Shihao Zheng, Qiuyue Wang, Wenying Qi, Jinchi Xie, Xiaobin Zao, Xiaoke Li, Peng Zhang, Yongan Ye. The Role of Chinese Medicine in the Treatment of Chronic Hepatitis B. The American Journal of Chinese Medicine 2025; 53(05) doi: 10.1142/S0192415X25500508
|
| 2 |
Lin Xiumei, He Guowei. Unresolved Issues in Chronic Hepatitis [Working Title]. 2026; doi: 10.5772/intechopen.1016003
|
| 3 |
Soe Thiha Maung, Roongruedee Chaiteerakij. Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B. Journal of Viral Hepatitis 2025; 32(7) doi: 10.1111/jvh.70040
|
| 4 |
Alice U. Lee, Martin Brand, Maria C. Cabrera, Naranjargal Dashdorj, Mohamed El-Kassas, Saeed Hamid, Kathy Jackson, Joseph K. Lim, C Wendy Spearman, Fu-Sheng Wang, Suna Yapali, Nancy Reau, Calvin Q. Pan. World Gastroenterology Organisation Practice Guidelines. Journal of Clinical Gastroenterology 2026; doi: 10.1097/MCG.0000000000002440
|
| 5 |
Lan-Lan Si, Zhen-Ping Fan, Wen-Hui Liu, Rong-Juan Chen, Xue-Yuan Chen, Dong Ji, Le Li, Chun Chen, Hao Liao, Jun Wang, Dong-Ping Xu, Jun Zhao, Yan Liu. Hepatitis B virus rtCYE/rtCYEI mutations may contribute limited tenofovir resistance: Analysis of a large sample of Chinese patients. World Journal of Hepatology 2025; 17(8): 107456 doi: 10.4254/wjh.v17.i8.107456
Abstract(234) |
Core Tip(226) |
Full Article(HTML)(607)
|
Full Article (PDF)-4293K(201)
|
Full Article with Cover (PDF)-4586K(75)
|
Full Article (XML)-116K(61)
|
Audio-1570K(6)
|
Peer-Review Report-249K(58)
|
Answering Reviewers-502K(57)
|
Supplementary Material-131K(50)
|
Times Cited (0)
|
Total Visits (1393)
|
Open
|